City Therapeutics Inc(CTY) 股價展望與企業分析 - PER·配息·財報·目標價·RSI·MACD

CTY

新增

City Therapeutics Inc

收盤價 10月23日 4:00 PM ET（韓國 10/24 05:00）

$20.77

+0.00 +0.00%

10月23日 4:00 PM ET（韓國 10/24 05:00）

$20.77

+0.00 +0.00%

詳細指標表

Index ⓘ	-	P/E ⓘ	-	EPS (ttm) ⓘ	-	Insider Own ⓘ	39.99%	Shs Outstand ⓘ	50.3M	Perf Week ⓘ	-7.28%
Market Cap ⓘ	1.07B	Forward P/E ⓘ	-	EPS next Y ⓘ	-	Insider Trans ⓘ	1.72%	Shs Float ⓘ	31.0M	Perf Month ⓘ	-
Enterprise Value ⓘ	-	PEG ⓘ	-	EPS next Q ⓘ	-	Inst Own ⓘ	11.39%	Short Float ⓘ	-	Perf Quarter ⓘ	-
Income ⓘ	-	P/S ⓘ	-	EPS this Y ⓘ	-	Inst Trans ⓘ	-	Short Ratio ⓘ	-	Perf Half Y ⓘ	-
Sales ⓘ	-	P/B ⓘ	-	EPS next 5Y ⓘ	-	ROA ⓘ	-	Short Interest ⓘ	-	Perf YTD ⓘ	-9.7%
Book/sh ⓘ	-	P/C ⓘ	-	EPS past 3/5Y ⓘ	-	ROE ⓘ	-	52W High ⓘ	-13.02% ($23.88)	Perf Year ⓘ	-
Cash/sh ⓘ	-	P/FCF ⓘ	-	Sales past 3/5Y ⓘ	-	ROIC ⓘ	-	52W Low ⓘ	5.16% ($19.75)	Perf 3Y ⓘ	-
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	-	EPS Y/Y TTM ⓘ	-	Gross Margin ⓘ	-	Volatility(W/M) ⓘ	6.39% -	Perf 5Y ⓘ	-
Dividend TTM ⓘ	-	EV/Sales ⓘ	-	Sales Y/Y TTM ⓘ	-	Oper. Margin ⓘ	-	ATR (14) ⓘ	1.7	Perf 10Y ⓘ	-
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	-	EPS Q/Q ⓘ	-	Profit Margin ⓘ	-	RSI (14) ⓘ	-	Recom ⓘ	-
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	-	Sales Q/Q ⓘ	-	SMA20 ⓘ	-1.61% ($21.11)	Beta ⓘ	-	Target Price ⓘ	-
Payout ⓘ	-	Debt/Eq ⓘ	-	Earnings ⓘ	-	SMA50 ⓘ	-1.61% ($21.11)	Rel Volume ⓘ	0.62	Prev Close ⓘ	$20.77
Employees ⓘ	-	LT Debt/Eq ⓘ	-	EPS/Sales Surpr. ⓘ	-	SMA200 ⓘ	-1.61% ($21.11)	Avg Volume(3M) ⓘ	0.55M	Price ⓘ	$20.77
IPO ⓘ	2026/10/16	Option/Short ⓘ	No/Yes			Trades ⓘ	1529	Volume ⓘ	343,849	Change ⓘ	-

公司資訊

City Therapeutics IncCTY | NASD | Biotechnology

🧬 리보핵산 간섭 기술로 질병과 관련된 단백질의 발현을 억제하는 차세대 치료제를 개발하는 임상 단계 바이오테크 기업입니다. 미국에 본사를 두고 있으며 혈전색전 질환, 스타가르트병 1형, 만성질환 빈혈을 겨냥한 파이프라인을 운영합니다. 최근 기업공개로 상장한 소형주입니다.

行情

過去一年中， 屬於偏低

較一年最高價低 13%。

現在 $20.77

52週最低$19.7552週最高$23.88

52週位置25%

343,849

成交量低於平時。相當於平均成交量的62%。